References

[1]  Department of Health and Ageing Vaccine Preventable Diseases in Australia, 2005–2007. Commun Dis Intell 2010; 34: .

[2]  Health NSW. Response Protocol for NSW Public Health Units. Pneumococcal Disease (Invasive). September 2004. Available from: http://www.health.nsw.gov.au/factsheets/guideline/pneumo.html (Cited 27 May 2011.)

[3]  Isaacman DJ, Fletcher MA, Fritzell B, Ciuryla V, Shranz J. Indirect effects associated with widespread vaccination of infants with heptavalent pneumococcal conjugate vaccine (PCV7;Prevenar). Vaccine 2007; 25: 2420–7..
| CrossRef |

[4]  Metlay JP, Fishman NO, Joffe M, Edelstein PH. Impact of pediatric vaccination with pneumococcal conjugate vaccine on the risk of bacteremic pneumococcal pneumonia in adults. Vaccine 2006; 24: 468–75.
| CrossRef | CAS |

[5]  Kellner JD, Vanderkooi OG, MacDonald J, Church DL, Tyrrell GJ, Scheifele DW. Changing epidemiology of invasive pneumococcal disease in Canada, 1998–2007: update from the Calgary-area Streptococcus pneumoniae research (CASPER) study. Clin Infect Dis 2009; 49: 205–12.
| CrossRef |

[6]  Sydney West Immunisation Strategy 2010–13. Parramatta: Centre for Population Health; 2010.

[7]  Dias R, Caniça M. Invasive pneumococcal disease in Portugal prior to and after the introduction of pneumococcal heptavalent conjugate vaccine. FEMS Immunol Med Microbiol 2007; 51: 35–42.
| CrossRef | CAS |

[8]  Lynch JP, Zhanel GG. Streptococcus pneumoniae: epidemiology and risk factors, evolution of antimicrobial resistance, and impact of vaccines. Curr Opin Pulm Med 2010; 16: 217–25.

[9]  Harboe ZB, Benfield TL, Valentiner-Branth P, Hjuler T, Lambersten L, Kaltoft M., et al. Temporal trends in invasive pneumococcal disease and pneumococcal serotypes over 7 decades. Clin Infect Dis 2010; 50: 329–37.
| CrossRef |

[10]  Liñares J, Ardanuy C, Pallares R, Fenoll A. Changes in anitmicrobial resistance, serotypes and genotypes in Streptococcus pneumoniae over a 30-year period. Clin Microbiol Infect 2010; 16: 402–10.
| CrossRef |